Grantham, Mayo, Van Otterloo & Co (GMO)’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CAH Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Cardinal Health (CAH) stake by 39% in Q1 2026, selling an estimated $250K and leaving 1,784 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #571.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CAH in Q2 2013 and has held it in 16 quarters since. The position peaked at $28.1M in Q2 2013. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 1,784 shares of Cardinal Health worth $377K as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,159 Cardinal Health shares in Q1 2026, an estimated $250K.
- Cardinal Health made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #571 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cardinal Health in Q2 2013 and has held it in 16 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Cardinal Health position peaked at $28.1M in Q2 2013.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.